Clinical trial
IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based…
NCT00351559 · XDx, Industry · Completed
Key facts
| NCT number | NCT00351559 |
|---|---|
| Title | IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection |
| Official title | Invasive Monitoring Attenuation Through Gene Expression (IMAGE) Trial |
| Lead sponsor | XDx, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Graft Rejection, Heart Diseases |
| Intervention type | Device, Procedure |
| Interventions | AlloMap molecular expression testing, Right ventricular endomyocardial biopsy |
| Enrollment | 629 |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2009 |
| First posted | Jul 13, 2006 |
| Last update posted | Nov 20, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: